Drug Trial Radar · NCT00930618
Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies
Last checked: Nov 20, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,409
Actual
Start
Jun 2009
Primary completion
Dec 2013
Study completion Apr 2014
Sponsor
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- URC-CIC Paris Descartes Necker Cochin
- First posted
- Jun 30, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to determine whether cervical ripening with isosorbide mononitrate reduce caesarean section in women with post term pregnancies.
Conditions
- Prolonged Pregnancy
- Nulliparity
Interventions
IMNDrug
Administration of 2 x 20 mg of isosorbide mononitrate at each administration with a maximum of three administrations
PlaceboDrug
Administration of 2 X 20 mg of placebo of IMN at each administration with a maximum of three administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of cesarean sectionsTime frame: 10 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Robert Debré Hospital
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.